期刊
CIRCULATION
卷 137, 期 6, 页码 543-545出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.117.032851
关键词
blood pressure monitoring; ambulatory; Japan
资金
- Teijin Pharma, Ltd
- Omron Healthcare Co, Ltd
- Fukuda Denshi
- Bayer Yakuhin, Ltd
- AD Co, Ltd
- Daiichi Sankyo Co, Ltd
- Mochida Pharmaceutical Co, Ltd
- EA Pharma
- Boehringer Ingelheim Japan Inc
- Tanabe Mitsubishi Pharma Corp
- Shionogi Co, Ltd
- MSD KK
- Sanwa Kagaku Kenkyusho Co, Ltd
- Bristol-Myers Squibb KK
- Grants-in-Aid for Scientific Research [26293192] Funding Source: KAKEN
The 2017 American Heart Association/American College of Cardiology (AHA/ACC) guidelines for the prevention, detection, evaluation, and management of high blood pressure (BP) in adults were recently released. 1 The core concept in these guidelines is earlier and tighter BP control over 24 hours, with the aim of providing more sustained target organ protection and cardiovascular disease prevention. These guidelines lower the threshold of hypertension diagnosis and target BP levels to 130/80 mm Hg. This direction of strict BP control with a new definition and universal target goal for hypertension will be the topic of debate among the guideline developing committee members of the Japanese Society of Hypertension.(2)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据